IDEAS home Printed from https://ideas.repec.org/p/rif/wpaper/130.html

Privacy Regulation and R&D Investments: Causal Evidence from Global Pharmaceutical and Biotechnology Firms

Author

Listed:
  • Koski, Heli

Abstract

This paper examines the effects of data privacy regulation on R&D investment in the pharmaceutical and biotechnology sectors. In these industries, access to personal health data is essential for innovation, particularly in clinical research. Leveraging a firm-level panel of the world’s top R&D investors from 2013 to 2023, we exploit the staggered implementation of major data protection regimes to estimate their causal impact. Using a dynamic event-study design, we find that stricter privacy regulation leads to a significant decline in R&D spending. By year four after implementation, treated firms reduced R&D investment by approximately 39 percent. The effects are heterogeneous: firms without foreign affiliates and small and medium-sized enterprises experience larger declines. Our findings suggest that privacy regulation may constrain the foundations of data-driven innovation and shape the geographic distribution of R&D activity.

Suggested Citation

  • Koski, Heli, 2025. "Privacy Regulation and R&D Investments: Causal Evidence from Global Pharmaceutical and Biotechnology Firms," ETLA Working Papers 130, The Research Institute of the Finnish Economy.
    • Handle: RePEc:rif:wpaper:130
    as

    Download full text from publisher

    File URL: https://www.etla.fi/wp-content/uploads/ETLA-Working-Papers-130.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Philippe Aghion & Nick Bloom & Richard Blundell & Rachel Griffith & Peter Howitt, 2005. "Competition and Innovation: an Inverted-U Relationship," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 120(2), pages 701-728.
    2. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    3. Philippe Aghion & Antonin Bergeaud & John Van Reenen, 2023. "The Impact of Regulation on Innovation," American Economic Review, American Economic Association, vol. 113(11), pages 2894-2936, November.
    4. Goodman-Bacon, Andrew, 2021. "Difference-in-differences with variation in treatment timing," Journal of Econometrics, Elsevier, vol. 225(2), pages 254-277.
    5. Daria Ciriaci & Nicola Grassano & Antonio Vezzani, 2016. "Regulation, Red Tape and Location Choices of Top R&D Investors," European Economy - Discussion Papers 031, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
    6. repec:hal:pseptp:halshs-04330712 is not listed on IDEAS
    7. Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(3), pages 1049-1090.
    8. Nick Bloom & Stephen Bond & John Van Reenen, 2007. "Uncertainty and Investment Dynamics," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 74(2), pages 391-415.
    9. Baker, Andrew C. & Larcker, David F. & Wang, Charles C.Y., 2022. "How much should we trust staggered difference-in-differences estimates?," Journal of Financial Economics, Elsevier, vol. 144(2), pages 370-395.
    10. Callaway, Brantly & Sant’Anna, Pedro H.C., 2021. "Difference-in-Differences with multiple time periods," Journal of Econometrics, Elsevier, vol. 225(2), pages 200-230.
    11. Blind, Knut, 2012. "The influence of regulations on innovation: A quantitative assessment for OECD countries," Research Policy, Elsevier, vol. 41(2), pages 391-400.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zhang, Siyu & Huang, Yuexin & Luo, Danglun, 2026. "Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China," Economic Analysis and Policy, Elsevier, vol. 89(C), pages 421-441.
    2. Byrski, Dennis & Wang, Lucy Xiaolu, 2025. "Marketing authorization and strategic patenting: Evidence from pharmaceuticals," Journal of Public Economics, Elsevier, vol. 247(C).
    3. Bao, Xiaohua & Ruan, Wen & Wei, Yaning & Wu, Wentao, 2026. "Innovation at crossroads: The effect of merger and acquisition on inventors’ creativity," China Economic Review, Elsevier, vol. 97(C).
    4. Bajo-Buenestado, Raúl & Borrella-Mas, Miguel Ángel, 2025. "Market competition and the adoption of clean technology: Evidence from the taxi industry," European Economic Review, Elsevier, vol. 174(C).
    5. Shirin, Farzana, 2023. "Does Teacher Salary Support Improve Student Learning Outcomes," 2023 Annual Meeting, July 23-25, Washington D.C. 335793, Agricultural and Applied Economics Association.
    6. Lin, Ling & Xiao, Min & Yao, Rongrong & Zhang, Xiaoying, 2024. "Product market liberalization and corporate cash holdings: Evidence from China," Pacific-Basin Finance Journal, Elsevier, vol. 86(C).
    7. Wu, Libo & Zhou, Yang, 2025. "Social norms and energy conservation in China," Resource and Energy Economics, Elsevier, vol. 82(C).
    8. Fisman, Raymond & Ghosh, Pulak & Sarkar, Arkodipta & Zhang, Jian, 2026. "Dirty air and green investments: The impact of pollution information on portfolio allocations," Journal of Financial Economics, Elsevier, vol. 182(C).
    9. Shipeng Yan & Wei Jiang & Yue Xu, 2026. "Global investors, hidden suppliers: how institutions shape the impact of stock market liberalization programs on corporate responsibility," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 57(2), pages 197-219, March.
    10. Wang, Lucy Xiaolu & Chan, Nathan W., 2026. "Legalization and innovation in the cannabis market," International Journal of Industrial Organization, Elsevier, vol. 106(C).
    11. Dong, Zhanyu & Cai, Jiayi & Li, Xuchao & Luan, Mengna, 2025. "Firm-level impacts and recovery dynamics following a public health crisis: Lessons from China’s SARS experience," Journal of Asian Economics, Elsevier, vol. 98(C).
    12. Ugur, Mehmet & Trushin, Eshref, 2018. "Asymmetric information and heterogeneous effects of R&D subsidies: evidence on R&D investment and employment of R&D personel," Greenwich Papers in Political Economy 21943, University of Greenwich, Greenwich Political Economy Research Centre.
    13. Dai, Xiang & Lv, Jin Roc & Yang, Chen, 2026. "Bankruptcy courts and capital structures," Economic Analysis and Policy, Elsevier, vol. 89(C), pages 57-72.
    14. Coraggio, Luca & Pagano, Marco & Scognamiglio, Annalisa & Tåg, Joacim, 2025. "JAQ of all trades: Job mismatch, firm productivity and managerial quality," Journal of Financial Economics, Elsevier, vol. 164(C).
    15. Mark Kattenberg & Bas Scheer & Jurre Thiel, 2023. "Causal forests with fixed effects for treatment effect heterogeneity in difference-in-differences," CPB Discussion Paper 452, CPB Netherlands Bureau for Economic Policy Analysis.
    16. Li, Pei & Liu, Kaihao & Lu, Yi & Peng, Lu, 2025. "Organizing regulatory structure and local air quality: Evidence from the environmental vertical management reform in China," Journal of Comparative Economics, Elsevier, vol. 53(1), pages 139-164.
    17. Han Hu & Shihui Yang & Lin Zeng & Xuesi Zhang, 2024. "U.S.–China trade conflicts and R&D investment: evidence from the BIS entity lists," Humanities and Social Sciences Communications, Palgrave Macmillan, vol. 11(1), pages 1-15, December.
    18. Zixi Lei & Xiaomeng Chen & Wen Wen & Andrew Whinston, 2026. "Rebuilding Startups: An Empirical Study on Remote Work and Skill Complementarity," Papers 2608.02666, arXiv.org.
    19. Bai, Min & Shen, Luxi & Li, Yue & Yu, Chia-Feng (Jeffrey), 2024. "Does legal justice promote stakeholder justice? Evidence from a judicial reform in China," International Review of Financial Analysis, Elsevier, vol. 94(C).
    20. Goran Petrevski, 2026. "Economic sanctions and output growth: Empirical evidence," International Economics and Economic Policy, Springer, vol. 23(4), pages 1-52, October.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • D22 - Microeconomics - - Production and Organizations - - - Firm Behavior: Empirical Analysis
    • K23 - Law and Economics - - Regulation and Business Law - - - Regulated Industries and Administrative Law
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D
    • O38 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Government Policy

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rif:wpaper:130. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Kaija Hyvönen-Rajecki (email available below). General contact details of provider: https://edirc.repec.org/data/etlaafi.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.